Skip to main content

Parallax Volatility Advisers, L.P.

Position in NVS — Novartis AG

CIK 1521001 San Francisco, CA

Position in NVS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$251,065
+$172,926 QoQ
Shares Held
1,602
+99.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,218
of 1,606 holders
Holding Since
Mar 2020
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NVS Over Time

Shares Held

Position Value (USD)

Derivatives in NVS

reported options exposure · as of Jun 30, 2026
CallValue
$0
CallShares
0
PutValue
$1,959,000
PutShares
12,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Parallax Volatility Advisers, L.P. holds $35,775,129 across 10 Drug Manufacturers - General names. NVS ranks #9 (0.7% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NVS

Export CSV
30 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,959,000 12,500
2026-06-30 $251,065 1,602
2024-12-31 $943,907 9,700
2024-12-31 $78,139 803
2024-09-30 $1,115,694 9,700
2024-06-30 $74,522 700
2024-06-30 $3,183,154 29,900
2023-12-31 $1,575,132 15,600
2023-09-30 $2,546,500 25,000
2023-06-30 $2,966,754 29,400
2023-03-31 $12,153,200 132,100
2023-03-31 $1,177,600 12,800
2022-12-31 $11,748,240 129,500
2022-12-31 $1,859,760 20,500
2022-09-30 $18,500,834 243,400
2022-09-30 $1,565,806 20,600
2021-12-31 $8,379,626 95,800
2021-12-31 $12,158,067 138,997
2021-12-31 $3,035,209 34,700
2021-09-30 $1,292,124 15,800
2021-09-30 $297,760 3,641
2021-09-30 $2,829,588 34,600
2020-12-31 $5,382 57
2020-12-31 $254,961 2,700
2020-09-30 $71,568 823
2020-09-30 $234,792 2,700
2020-06-30 $270,754 3,100
2020-06-30 $1,397 16
2020-03-31 $8,245 100
2020-03-31 $1,286,220 15,600